Financials
2026
Entry into a Material Definitive Agreement
Current report, 10 Feb 2026
8-K
Director or Officer Departures, Elections, Appointments, and Compensation Arrangements
Current report, 06 Feb 2026
8-K
Regulation FD Disclosure
Current report, 12 Jan 2026
8-K
2025
Damora Therapeutics, Inc. annual report, FY2025
Annual report, FY2025
10-K
Unregistered Sales of Equity Securities
Current report, 31 Dec 2025
8-K
Entry into a Material Definitive Agreement
Current report, 10 Nov 2025
8-K
Damora Therapeutics, Inc. quarterly report, Q3 FY2025
Quarterly report, Q3 FY2025
10-Q
Damora Therapeutics, Inc. quarterly report, Q2 FY2025
Quarterly report, Q2 FY2025
10-Q
Submission of Matters to a Vote of Security Holders
Current report, 18 Jun 2025
8-K
Damora Therapeutics, Inc. quarterly report, Q1 FY2025
Quarterly report, Q1 FY2025
10-Q